Source: Eur Respir Monogr 2011; 51: 16-27
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Sumino, R. Djukanovic, M. Castro. Evaluation of the difficult-to-treat severe asthma patient in the clinic. Eur Respir Monogr 2011; 51: 16-27

Member's Comments

No comment yet.

Related content which might interest you: Management of severe and difficult-to-treat asthma Source: Annual Congress 2013 –Severe asthma: moving from phenotyping to endotyping Year: 2013 Management of difficult-to-treat severe asthma Source: Eur Respir Mon 2011; 51: 282-296 Year: 2011 Systematic assessment of difficult-to-treat asthma Source: Eur Respir J 2003; 22: 478-483 Year: 2003 Combination asthma medication and healthcare use in severe or difficult-to-treat asthma Source: Eur Respir J 2004; 24: Suppl. 48, 131s Year: 2004 The use of omalizumab in the management of severe chronic paediatric asthma Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma Year: 2008 Characteristics and medication use of the patients with acute exacerbations of asthma-COPD overlap syndrome Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015 Evaluation and management of difficult-to-control asthma Source: Annual Congress 2004 - PG12 - Asthma: from bench to bedside Year: 2004 Predictors of severe asthma exacerbations, poor asthma control and beta-agonist overuse in adult asthma Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Prevalence of co-morbidities in severe asthma, COPD and overlap syndrome Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Characterisation of patients with difficult-to-treat and treatment-resistant severe asthma Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers Year: 2012 Risk factors of frequent exacerbations in difficult-to-treat asthma Source: Eur Respir J 2006; 27: 1324-1325 Year: 2006 Antibiotics use for asthma exacerbation in Japanese geriatric patients Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies Year: 2019 Dupilumab reduces severe exacerbations in periostin-high and periostin-low asthma patients Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives Year: 2016 Comorbidities in severe asthma Source: International Congress 2019 – State of the art session: Airway disease Year: 2019 Recurrent exacerbation of asthma: Characteristics of the patients and risk factors Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015 Adherence and effectiveness of omalizumab treatment in severe allergic asthma patients: Do the patients like injectable treatment? Source: Annual Congress 2013 –Treatment of asthma Year: 2013 The management of acute life-threatening asthma Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=396 Year: 2003 Predictors of effectiveness of omalizumab treatment in patients with severe asthma recruited in a real-life setting Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015 Comorbidities – should we and how should we treat them in asthma and COPD? Source: International Congress 2014 – PG02 Current clinical problems in pulmonology Year: 2014 Risk factors for severe exacerbations in a real-life population of adults with severe refractory asthma Source: International Congress 2017 – Many faces of asthma and allergies Year: 2017